We are pleased to feature our current sponsors and partners of the SLoT Forum 2016. We hugely value their support in enabling the Leaders of Tomorrow to connect with leading experts in biotechnology in order to collaboratively discuss solutions to the challenges in addressing Asian phenotypic Diseases in Asia.
The Agilent business in Singapore plays a number of significant roles within the region.
It is the Asia Pacific hub for finance and administration, customer care and technical support. Singapore is also a significant manufacturing site and a regional center for many other Agilent businesses including life sciences and chemical analysis.
With over 400 employees, the company encourages a buddy system to build team-work. We also play an active role in helping ensure social responsibility. Our employees are part of a rich Agilent culture that is diverse and yet shares the same Agilent values of speed, focus and accountability. These values empower employees to make a difference, to be creative and to take risks and provide solutions for our customers.
The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit society.
As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by contributing to societal benefits such as improving outcomes in healthcare, urban living, and sustainability.
We play a key role in nurturing and developing a diversity of talent and leaders in our Agency and Research Institutes, the wider research community and industry. A*STAR oversees 18 biomedical sciences and physical sciences and engineering research entities primarily located in Biopolis and Fusionopolis.
STEMCELL Technologies Inc. is a Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research. Driven by science and a passion for quality, STEMCELL supports the advancement of scientific research around the world with our catalogue of more than 2000 cell biology research tools.
STEMCELL Technologies was launched in 1993 when founder and CEO Allen Eaves needed a way to meet the increasing demands for his standardized, cost-effective cell culture media for growing blood-forming stem cells. At the time, Eaves was a hematologist and cancer researcher heading the Terry Fox Laboratories (TFL) and head of clinical hematology at the University of British Columbia in Vancouver, Canada. Unsatisfied with commercially available cell culture reagents, Eaves’ research group at the TFL began making their own hematopoietic stem cell culture media using the highest quality materials they could find. Colleagues also wanted to use this media, and Eaves was able to supplement his research funds by selling culture media to other lab groups.
Eventually the demand for the media from researchers around the world warranted building a designated clean room for production. The TFL did not have the funding and instead, Eaves was encouraged to purchase the business and create an independent company. Mortgaging his house and receiving a loan from Western Economic Diversification, Eaves was able to build a clean room and STEMCELL Technologies Inc. was born on July 2, 1993. STEMCELL has become the largest biotech company in Canada and continues to reinvest all profits back into developing products to better support the international research community. As of 2016, the company employs more than 800 people globally, with over one-third of those holding a PhD or MSc, and the majority of employees having a BSc or Engineering degree. A large number of the company’s employees are located in Vancouver, Canada with additional employees and facilities in 11 other countries.
The Croeni Foundation was set up in 2015 to tackle some of major challenges of this millennium: GIVING, ENVIRONMENT, HEALTH.
Our VISION is to enable people, animals and charities to live happier, healthier and longer.
GRANT MAKER Meaningful grants to selected long-term partners who go to the root of problems, are accountable and aim to make themselves redundant within a clear time frame.
OWN PROGRAMS We start and run own programs, if they make sense and until suitable partner could be identified to take them over.
THINKING LONGTERM Our grants and programs are committed over the next 10 years until 2025; allowing initiatives, partners and impact to fine-tune continuously and stay focused on achieving highest possible impact within the next decade.
Spurwing Communications is a strategic advisory with expertise in healthcare communications. Spurwing is trusted to deliver proactive and intelligent corporate and financial communications and investor relations counsel to senior decision makers of world-leading businesses.
An independent specialist, we are committed to helping clients to promote, develop and defend respected reputations and long-term value.
Our advice is founded upon deep sector experience and expertise, with an uncompromising focus on providing high-quality, senior advice and insight.